Hara Naofumi, Fujimoto Nobukazu, Miyamoto Yosuke, Yamagishi Tomoko, Asano Michiko, Fuchimoto Yasuko, Wada Sae, Ozaki Shinji, Nishi Hideyuki, Kishimoto Takumi
Department of Respiratory Medicine, Okayama Rosai Hospital.
Drug Discov Ther. 2016;10(2):114-6. doi: 10.5582/ddt.2016.01005. Epub 2016 Feb 15.
An 81-year-old woman visited a local clinic due to chest pain and a skin induration on the right precordia. She had a history of right breast cancer, and she had undergone a mastectomy and radiation therapy 10 years prior. Computed tomography (CT) imaging of the chest demonstrated a lobular mass that involved the right anterior thoracic wall and partially extruded from the thoracic cavity into the subcutaneous tissue. The tumor was surgically excised, and pathological analyses yielded a diagnosis of angiosarcoma. Five months after the operation, CT imaging showed multiple masses on the right pleura, indicating a local relapse and pleural dissemination of the angiosarcoma. Systemic chemotherapy composed of nanoparticle albumin-bound paclitaxel (nab-PTX) (80 mg/m(2)) was delivered weekly. After 4 courses of chemotherapy, the tumors regressed remarkably. Nab-PTX may be an effective treatment option for recurrent or metastatic angiosarcoma.
一名81岁女性因胸痛和右胸前区皮肤硬结就诊于当地诊所。她有右乳腺癌病史,10年前接受了乳房切除术和放射治疗。胸部计算机断层扫描(CT)成像显示一个小叶状肿块,累及右前胸壁,部分从胸腔突出至皮下组织。肿瘤经手术切除,病理分析诊断为血管肉瘤。术后5个月,CT成像显示右胸膜有多个肿块,提示血管肉瘤局部复发和胸膜播散。给予每周一次的纳米白蛋白结合紫杉醇(nab-PTX)(80 mg/m²)全身化疗。4个疗程化疗后,肿瘤明显消退。nab-PTX可能是复发性或转移性血管肉瘤的有效治疗选择。